A phase 1/2 study of ubamatamab (REGN4018): low-grade serous ovarian cancer expansion cohort

International Journal of Gynecological Cancer 2026

View at publisher
Authors: Els Van Nieuwenhuysen, Florence Joly, Judith Michels, Anna K.L. Reyners, Oladapo Yeku, Suk‐Young Yoo, Bin Wang, Jurriaan Brouwer‐Visser, Mihaela C. Cristea, Nicole Costigan, Mary Jane Peterman, Israel Lowy
+4 more Brigid Barnes, Gloria Shining Huang, Elizabeth C. Miller, Thomas S. Uldrick
DOI: 10.1016/j.ijgc.2025.103202
Cited by: 0

Fields of Study & Subjects

Ovarian cancer diagnosis and treatment Monoclonal and Polyclonal Antibodies Research Ovarian function and disorders

Publication details

Journal / source
International Journal of Gynecological Cancer
Volume
36
Issue
2
Pages
103202–103202
Publication date
1 February 2026
Language
EN